Adjuvant materials that enhance bovine γδ T cell responses.
Despite the availability of vaccines and antibiotics, viral, bacterial and parasite-induced intestinal and pulmonary diseases still cause significant losses to the livestock industry. Excepting improvements in calf survival due to predation, there have been only modest improvements in bovine calf survival since 1991. Strikingly, digestive and respiratory diseases still account for almost half of the non-predator deaths in calves. The innate immune system has evolved to rapidly recognize and respond to invasive microbial threats. Augmentation of innate immunity is a broad-spectrum, potent and non-specific alternative approach to effectively counter a microbial invasion. In recent years we have focused our research efforts on the development of effective and inexpensive adjuvant therapies for cattle that can be used to help mitigate infection. Unique in our approach to the development of the potential new treatments, is our focus on bovine γδ T cells, which are important lymphocytes of the innate immune system and of particular importance to ruminant immunological health. This review focuses on recent results obtained using two such adjuvant materials.